Skip to main content
Journal cover image

EGF RECEPTOR TYROSINE KINASE MEDIATES A NOVEL PATHWAY OF DRUG RESISTANCE IN MALIGNANT GLIOMAS VIA TYROSINE PHOSPHORYLATION AND FUNCTIONAL ACTIVATION OF GLUTATHIONE S-TRANSFERASE P1

Publication ,  Journal Article
Okamura, T; Singh, S; Buolamwini, JK; Friedman, HS; Bigner, DD; Ali-Osman, F
Published in: NEURO-ONCOLOGY
April 1, 2009

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

April 1, 2009

Volume

11

Issue

2

Start / End Page

218 / 218

Location

Tokyo, JAPAN

Publisher

DUKE UNIV PRESS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Okamura, T., Singh, S., Buolamwini, J. K., Friedman, H. S., Bigner, D. D., & Ali-Osman, F. (2009). EGF RECEPTOR TYROSINE KINASE MEDIATES A NOVEL PATHWAY OF DRUG RESISTANCE IN MALIGNANT GLIOMAS VIA TYROSINE PHOSPHORYLATION AND FUNCTIONAL ACTIVATION OF GLUTATHIONE S-TRANSFERASE P1. NEURO-ONCOLOGY, 11(2), 218–218.
Okamura, Tatsunori, Simendrah Singh, John K. Buolamwini, Henry S. Friedman, Darell D. Bigner, and Francis Ali-Osman. “EGF RECEPTOR TYROSINE KINASE MEDIATES A NOVEL PATHWAY OF DRUG RESISTANCE IN MALIGNANT GLIOMAS VIA TYROSINE PHOSPHORYLATION AND FUNCTIONAL ACTIVATION OF GLUTATHIONE S-TRANSFERASE P1.” NEURO-ONCOLOGY 11, no. 2 (April 1, 2009): 218–218.
Okamura T, Singh S, Buolamwini JK, Friedman HS, Bigner DD, Ali-Osman F. EGF RECEPTOR TYROSINE KINASE MEDIATES A NOVEL PATHWAY OF DRUG RESISTANCE IN MALIGNANT GLIOMAS VIA TYROSINE PHOSPHORYLATION AND FUNCTIONAL ACTIVATION OF GLUTATHIONE S-TRANSFERASE P1. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2009 Apr 1;11(2):218–218.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

April 1, 2009

Volume

11

Issue

2

Start / End Page

218 / 218

Location

Tokyo, JAPAN

Publisher

DUKE UNIV PRESS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences